PRINCETON - Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a clinical-stage biotechnology company specializing in immunotherapy treatments with a current market capitalization of $4.69 ...
PRINCETON, N.J. - Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a clinical-stage biotechnology company with a market capitalization of $4.69 million, announced its intention to further ...
PRINCETON, N.J. - Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a clinical-stage biotechnology company with a market capitalization of $4.69 million, announced its intention to further develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback